Browse: Departments Dates Agencies
SUBJECT CATEGORY: Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. and Foreign Patents and Patent Applications Concerning Indolo [2,1-B] Quinazole-6,12-Dione Antimalarial Compounds and Methods of Treating Malaria
DOCUMENT SUMMARY: In accordance with 37 CFR Part 404.6 and 404.7, announcement is made of the availability for licensing of inventions set forth in the following, related patent applications:
1. Title: Indolo [2,1B] Quinazole6, 12Dione Antimalarial Compounds and Methods of Treating Malaria.
U.S. Patent No.: 6,531,487.
Issued: March 11, 2003.
2. Title: Indolo [2,1B] Quinazole6, 12Dione Antimalarial Compounds and Methods.
U.S. Patent No.: 6,284,772.
Issued: September 28, 1999.
Foreign rights are also available. The United States Government, as represented by the Secretary of the Army, has rights in these inventions.
SUMMARY: Indolo [2,1-B]quinazole-6, 12-dione antimalarial compounds and malaria treatment methods,
FOR FURTHER INFORMATION CONTACT For patent issues, Ms. Elizabeth
Arwine, Patent Attorney, (301) 6197808. For licensing issues, Dr. Paul
Mele, Office of Research & Technology Applications, (301) 6196664, both at telefax (301) 6195034.
Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 0326431 Filed 102003; 8:45 am]
BILLING CODE 371008M
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 50 CFR Part 679 47 CFR Part 73 26 CFR Part 1 40 CFR Part 180 33 CFR Part 117 50 CFR Part 17 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 33 CFR Part 100 40 CFR Part 63 50 CFR Part 622 44 CFR Part 65 50 CFR Part 660 26 CFR Part 301 39 CFR Part 111 40 CFR Part 300 6 CFR Part 5 40 CFR Part 271 47 CFR Part 64 40 CFR Parts 52 and 81 50 CFR Part 665 44 CFR Part 64 10 CFR Part 50 49 CFR Part 571 47 CFR Part 76